About Andrew Marshall
Andrew Marshall is the chief executive officer of 511 Therapeutics, a biotechnology company. He is also a director of the company.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Andrew Marshall in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Marshall works with at each company, as listed on that company's latest Form D.
511 Therapeutics, Inc. · Form D, Oct 30, 2026